Sanofi Blew Whistle On Mylan's EpiPen Rebate Woes: Feds
Mylan will pay $465 million to resolve allegations that it ripped off the government by underpaying rebates for the EpiPen, federal authorities said Thursday, revealing for the first time that competitor...To view the full article, register now.
Already a subscriber? Click here to view full article